List of Arvinas patents

List of Arvinas patents

List of Esteve patents

List of Arrowhead Medical Device Technologies patents

List of FaceFirst patents

List of SBIR/STTR awards granted to Naprogenix, Inc.

List of hospitals and health care companies

Patents where

Current Assignee

Name

is

Arvinas

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11597720 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders		Arvinas	Arvinas		United States Patent and Trademark Office	11597720	March 7, 2023
	‌ US Patent 11384063 Modulators of estrogen receptor proteolysis and associated methods of use	Patent 11384063 was granted and assigned to Arvinas on July, 2022 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11384063	July 12, 2022
	‌ US Patent 11191741 Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide	Patent 11191741 was granted and assigned to Arvinas on December, 2021 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11191741	December 7, 2021
	‌ US Patent 11065231 Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides	Patent 11065231 was granted and assigned to Arvinas on July, 2021 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11065231	July 20, 2021
	‌ US Patent 11236051 Compounds and methods for the targeted degradation of androgen receptor	Patent 11236051 was granted and assigned to Arvinas on February, 2022 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11236051	February 1, 2022
	‌ US Patent 10584101 Compounds and methods for the targeted degradation of androgen receptor	Patent 10584101 was granted and assigned to Arvinas on March, 2020 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	10584101	March 10, 2020
	‌ US Patent 11458123 Tau-protein targeting PROTACs and associated methods of use		Arvinas	Arvinas		United States Patent and Trademark Office	11458123	October 4, 2022
	‌ US Patent 11427548 Compounds and methods for the targeted degradation of androgen receptor	Patent 11427548 was granted and assigned to Arvinas on August, 2022 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11427548	August 30, 2022
	‌ US Patent 11352351 Compounds and methods for the targeted degradation of androgen receptor	Patent 11352351 was granted and assigned to Arvinas on June, 2022 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11352351	June 7, 2022
	‌ US Patent 11584743 Indole derivatives as estrogen receptor degraders	Patent 11584743 was granted and assigned to Arvinas on February, 2023 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11584743	February 21, 2023
	‌ US Patent 10844021 Compounds and methods for the targeted degradation of androgen receptor	Patent 10844021 was granted and assigned to Arvinas on November, 2020 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	10844021	November 24, 2020
	‌ US Patent 10946017 Tank-binding kinase-1 PROTACs and associated methods of use	Patent 10946017 was granted and assigned to Arvinas on March, 2021 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	10946017	March 16, 2021
	‌ US Patent 10647698 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders	Patent 10647698 was granted and assigned to Arvinas on May, 2020 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	10647698	May 12, 2020
	‌ US Patent 10899742 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders	Patent 10899742 was granted and assigned to Arvinas on January, 2021 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	10899742	January 26, 2021
	‌ US Patent 10865202 Indole derivatives as estrogen receptor degraders		Arvinas	Arvinas		United States Patent and Trademark Office	10865202	December 15, 2020
	‌ US Patent 11104666 Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders	Patent 11104666 was granted and assigned to Arvinas on August, 2021 by the United States Patent and Trademark Office.	Arvinas	Arvinas		United States Patent and Trademark Office	11104666	August 31, 2021
	‌ US Patent 10604506 Modulators of estrogen receptor proteolysis and associated methods of use		Arvinas	Arvinas		United States Patent and Trademark Office	10604506	March 31, 2020
	‌ US Patent 11707452 Modulators of alpha-synuclein proteolysis and associated methods of use		Arvinas	Arvinas		United States Patent and Trademark Office	11707452	July 25, 2023

18 results

0 selected

18 results

0 selected